Combined Blood Flow Restriction Training and Betaine Supplementation Impacts on Serum Betaine and Homocysteine Concentrations

Homocysteine (HCY) is a clinically implicated in inflammation and cardiovascular impairments. Although both betaine supplementation and acute resistance (both high-load [HL] and low-load blood flow restriction [LL-BFR]) training notably attenuate HCY concentrations, it is hitherto unknown if these independent modalities synergistically interact. PURPOSE: to determine whether a combination of betaine supplementation, as well as acute HL and/or LL-BFR training can attenuate post-exercise HCY more effectively than either isolated modality. METHODS: Eighteen recreationally trained males (25±5y) were randomized in double-blind fashion to supplement 6g/day of either betaine anhydrous (BET) or identically dosed cellulose placebo for 14-days. Subsequently, all subjects performed four standardized sets of one-leg press and two additional sets to muscular failure on both legs in a counter-balanced and crossover design. Specifically, one leg performed standard high-load (HL; 70%1RM) exercise and contralateral limb underwent BFR (LL-BFR; 20%1RM) training at 80% arterial occlusion pressure. Serum homocysteine (HCY) and betaine (BET) concentrations were analyzed before and 30-minutes post-exercise prior to quantification via ELISA and liquid chromatography-mass spectrometry, respectively. The changes in all aforementioned variables from baseline (∆HCY and ∆BET) were assessed via separate two-way mixed model ANOVA with repeated measures at a significance level of pRESULTS: Analyses failed to reveal any significant main nor interaction effects for serum ∆BET. Although no apparent main supplement nor interaction effects were observed, ∆HCY demonstrated a significant main exercise condition effect (p=.045; ηp2=.228), whereby the LL-BFR group displayed significantly greater concentrations versus HL (p=.045). CONCLUSION: While these findings ultimately do not support a betaine-resistance training synergy-mediated reduction in serum HCY, our data otherwise suggest BFR training may preferentially result in lower post-training concentrations relative to a commonly employed, high-load approach. Future research should elucidate the credence of this interpretation via additional longitudinal investigations amidst hyperhomocysteinemia-predisposed clinical populations

Influence of acetylsalicylic acid on hematotoxicity of benzene

Objectives: The aim of the study was to evaluate the influence of acetylsalicylic acid (ASA) on benzene hematotoxicity in rats. Materials and Methods: The study was carried out on rats exposed for 2, 4 and 8 weeks to benzene vapour at a conentration of 1.5 or 4.5 mmol/m3 of air (5 days per week, 6 hours per day) alone or together with ASA at the doses of 5, 150 or 300 mg/kg body weight (per os). Results: Benzene at a concentration of 4.5 mmol/m3 caused a slight lymphopenia, granulocytosis and reticulocytosis in blood. In bone marrow traits of megaloblastic renewal, presence of undifferentiated cells and giant forms of granulocytes as well as an increase in myeloperoxidase and decrease in chloroacetate esterase activity and lipids content were noted. ASA (150 and 300 mg/kg b.w.) influenced some of hematological parameters, altered by benzene intoxication. ASA limited the solvent-induced alteration in blood reticulocyte count and in the case of bone marrow in the erythroblasts count. Traits of megaloblastic renewal in bone marrow were less pronounced. Besides, higher activity of myeloperoxidase and the decrease in the level of lipids in granulocytes were noted. Conclusion: Our results suggest that ASA limited the benzene-induced hematotoxicity

Cardiac lymphatics in health and disease

The lymphatic vasculature, which accompanies the blood vasculature in most organs, is indispensable in the maintenance of tissue fluid homeostasis, immune cell trafficking, and nutritional lipid uptake and transport, as well as in reverse cholesterol transport. In this Review, we discuss the physiological role of the lymphatic system in the heart in the maintenance of cardiac health and describe alterations in lymphatic structure and function that occur in cardiovascular pathology, including atherosclerosis and myocardial infarction. We also briefly discuss the role that immune cells might have in the regulation of lymphatic growth (lymphangiogenesis) and function. Finally, we provide examples of how the cardiac lymphatics can be targeted therapeutically to restore lymphatic drainage in the heart to limit myocardial oedema and chronic inflammation.Peer reviewe

Proceedings of the Thirteenth International Society of Sports Nutrition (ISSN) Conference and Expo

Meeting Abstracts: Proceedings of the Thirteenth International Society of Sports Nutrition (ISSN) Conference and Expo Clearwater Beach, FL, USA. 9-11 June 201